Offerings Archives - Page 36 of 166

1 minute read

Golden Minerals Announces $4.2M Public Offering

November 6, 10:16 AM

Golden Minerals Company ("Golden Minerals", "Golden" or the "Company") (NYSE:AUMN, TSX:AUMN) is pleased to announce the pricing of its public offering of an aggregate of 6,000,000 shares of its common stock (or common

AUMN

9 minute read

NANOBIOTIX Announces Pricing Of A Capital Increase Raising Total Gross Proceeds Of $55M An Offering Of 3,106,907 American Depositary Shares At An Offering Price Of $5.36 Per ADS

By Benzinga Newsdesk

November 2, 10:53 AM

NBTX – "Nanobiotix" or the "Company"), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the pricing of its previously

NBTX

6 minute read

Aileron Therapeutics Announces Acquisition Of Lung Therapeutics; Financing Proceeds Of ~$18M From A Private Placement Anticipated To Fund Completion Of The Ongoing Phase 1b Clinical Study Of LTI-03 In IPF And For General Corporate Purposes

By Benzinga Newsdesk

October 31, 12:36 PM

Acquisition includes multiple clinical stage, orphan pulmonary disease candidates, including LTI-03, a Caveolin-1-related peptide in development for the treatment of idiopathic pulmonary fibrosis (IPF)Financing

ALRN

1 minute read

Biofrontera Inc. Announces $4.5M Registered Direct Offering Priced At-The-Market Under NASDAQ Rules

By Benzinga Newsdesk

October 31, 11:48 AM

Biofrontera Inc.

BFRI

1 minute read

Avenue Therapeutics Announces Pricing Of $5M Public Offering

By Benzinga Newsdesk

October 31, 9:20 AM

Avenue Therapeutics, Inc. (NASDAQ:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today

ATXI

1 minute read

Netcapital Funding Portal Success Story Avadain Raises $4.5M In Sold-Out Capital Offering

By Benzinga Newsdesk

October 31, 8:37 AM

Netcapital Inc. (NASDAQ:NCPL, NCPLW)))) (the "Company"), a digital private capital markets ecosystem, today announced the successful completion of a $4.5 million capital offering by U.S.-based graphene technology

NCPL

1 minute read

Worksport Announces Pricing Of Approximately $4.7M Registered Direct Offering & Concurrent Private Placement

By Benzinga Newsdesk

October 31, 8:13 AM

Worksport Ltd. (NASDAQ:WKSP, WKSPW))) ("Worksport" or the "Company") is pleased to announce today that it has entered into a securities purchase agreement with a single institutional investor to purchase 3,500,000 shares

WKSP

1 minute read

Vivos Therapeutics Announces Pricing Of $4M Private Placement Priced At-the-Market Under Nasdaq Rules

By Benzinga Newsdesk

October 31, 8:11 AM

Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderate

VVOS

1 minute read

Annovis Bio Announces Pricing Of $7.5M Public Offering

By Benzinga Newsdesk

October 31, 8:03 AM

Annovis Bio, Inc. (NYSE:ANVS) ("Annovis"), a late-stage clinical drug platform company developing transformative therapies to treat neurodegenerative diseases, including Alzheimer's Disease and Parkinson's Disease, today

ANVS

1 minute read

Orgenesis Announces Proposed Underwritten Public Offering; No Size Or Amount Disclosed

By Benzinga Newsdesk

October 30, 5:00 PM

Orgenesis Inc. (NASDAQ:ORGS) ("Orgenesis" or the "Company"), a global biotech company working to unlock the full potential of cell and gene therapies (CGT), today announced it has commenced an underwritten public

ORGS